Yilin Li

Weifang Medical University

Papers

1

Total Citations

34

H-Index

1

About

Dr. Yilin Li has made significant contributions to gynecologic oncology, with a primary focus on optimizing surgical outcomes for cervical cancer patients. Her most cited work, a 2021 systematic review and meta-analysis comparing minimally invasive surgery (MIS) to open surgical treatments for early-stage cervical cancer, has garnered 34 citations and critically evaluated the trade-offs between intraoperative and postoperative complications. This research addresses a pivotal clinical debate, providing evidence that laparotomy may offer superior disease-free and overall survival compared to MIS, despite the latter's benefits in recovery. Dr. Li’s work is instrumental in guiding surgeons and patients toward more informed treatment decisions, balancing oncologic safety with quality of life. Her meta-analytical approach demonstrates a rigorous commitment to evidence-based medicine, synthesizing complex data to clarify best practices. Through this impactful study, Dr. Li has established herself as a key voice in refining surgical standards for cervical cancer, with her findings influencing clinical guidelines and sparking further investigation into surgical modalities. Her dedication to improving patient outcomes through comparative effectiveness research marks her as a rising authority in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
34
Total Citations
34
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of the complications between minimally invasive surgery and open surgical treatments for early-stage cervical cancer: A systematic review and meta-analysis
34 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Weifang Medical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago